All In MedTech

Company

Intervascular

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Intervascular, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Intervascular.

Latest FDA decisions

Search the Clearance Tracker

No 510(k), De Novo or PMA decisions under this name since 2015.

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07322913 · 1,200 participants (planned) · Start Dec 19, 2025 · Primary completion Jul 2027

    Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches; Hemashield - Collagen Coated Vascular Grafts and Patches and 2 more · For: Carotid Artery Diseases; Aortic Diseases; Peripheral Arterial Diseases

    Sites: Hershey, Pennsylvania; Pittsburgh, Pennsylvania; Leuven, Belgium · 5 sites in all

Reports received

62

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

35

56% of reports

Injury reports

25

40% of reports

Death reports

2

3.2% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230400
Jan 242000
Feb 240000
Mar 241020
Apr 240000
May 240400
Jun 242600
Jul 240310
Aug 241000
Sep 240000
Oct 2412000
Nov 242000
Dec 242010
Jan 253010
Feb 250000
Mar 251000
Apr 253300
May 251300
Jun 251520
Jul 252500
Aug 252100
Sep 252200
Oct 253400
Nov 251000
Dec 251000
Jan 261100
Feb 260200
Mar 2613700
Apr 266200
May 262800
Jun 260200
Jul 262000
Aug 268000
Sep 261100
Oct 260220
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.